The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment tolerance, tumor response, and clinical toxicity associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small cell lung cancer (NSCLC) in Chinese patients.
Yan Wang
No relevant relationships to disclose
Jianhua Chen
No relevant relationships to disclose
Shengqi Wu
No relevant relationships to disclose
Chengping Hu
No relevant relationships to disclose
Xiaoling Li
No relevant relationships to disclose
Yuqin Wang
No relevant relationships to disclose
Yicheng Yang
Employment or Leadership Position - Lilly
Yun Chen
Employment or Leadership Position - Lilly
Narayan Rajan
Employment or Leadership Position - Lilly
Yi Chen
Employment or Leadership Position - Normin Health
Zhuanzhuan Luo
Employment or Leadership Position - Normin Health
Wendong Chen
Employment or Leadership Position - Normin Health
Consultant or Advisory Role - Lilly
Honoraria - Lilly
Research Funding - Lilly